Kanser Tanımı ve Tarihçesi

Hanahan D, Weinberg RA. The hallmarks of cancer. Cell [Internet]. 2000 Jan 7 [cited 2022 Jan 2];100(1):57–70. Available from: https://pubmed.ncbi.nlm.nih.gov/10647931/

Hanahan D, Weinberg RA. Hallmarks of cancer: The next generation. Cell. 2011 Mar 4;144(5):646–74.

Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229–63.

Sever A, Toy Y, Erdoğan MK, Gündoğdu R. Kemoterapide Kullanılan Güncel Fitokimyasallar. Muş Alparslan Üniversitesi Sağlık Bilim Derg. 2023;3(1):64–76.

Blackadar CB. Historical review of the causes of cancer. World J Clin Oncol. 2016;7(1):54–86.

Katzke VA, Kaaks R, Kühn T. Lifestyle and cancer risk. Cancer J. 2015;21(2):104–10.

Ashford NA, Bauman P, Brown HS, Clapp RW, Finkel AM, Gee D, et al. Cancer risk: role of environment. Science (80- ). 2015;347(6223):727.

Toy Y, Gundogdu R, Sever A, Erdoğan Mk. Defektif Homolog Rekombinasyon DNA Tamiri ve PARP İnhibisyonu Arasındaki Sentetik Letal Etkileşim. J Inst Sci Technol. 12(4):2459–75.

Schiller JT, Lowy DR. Virus infection and human cancer: an overview. Viruses Hum Cancer from Basic Sci to Clin Prev. 2013;1–10.

Tu H, Wen CP, Tsai SP, Chow W-H, Wen C, Ye Y, et al. Cancer risk associated with chronic diseases and disease markers: prospective cohort study. Bmj. 2018;360.

Maman S, Witz IP. A history of exploring cancer in context. Nat Rev Cancer. 2018;18(6):359–76.

Patel A. Benign vs malignant tumors. JAMA Oncol. 2020;6(9):1488.

Geiger TR, Peeper DS. Metastasis mechanisms. Biochim Biophys Acta (BBA)-Reviews Cancer. 2009;1796(2):293–308.

Yin H, Qu J, Peng Q, Gan R. Molecular mechanisms of EBV-driven cell cycle progression and oncogenesis. Med Microbiol Immunol. 2019;208:573–83.

Matthew J, Vishwakarma V, Le TP, Agsunod RA, Chung S. Coordination of cell cycle and morphogenesis during organ formation. Elife. 2024;13:e95830.

Carlton JG, Jones H, Eggert US. Membrane and organelle dynamics during cell division. Nat Rev Mol Cell Biol. 2020;21(3):151–66.

Li H, Peng X, Wang Y, Cao S, Xiong L, Fan J, et al. Atg5-mediated autophagy deficiency in proximal tubules promotes cell cycle G2/M arrest and renal fibrosis. Autophagy. 2016;12(9):1472–86.

Sun P, Wu H, Huang J, Xu Y, Yang F, Zhang Q, et al. Porcine epidemic diarrhea virus through p53-dependent pathway causes cell cycle arrest in the G0/G1 phase. Virus Res. 2018;253:1–11.

Nakayama K-I, Hatakeyama S, Nakayama K. Regulation of the cell cycle at the G1–S transition by proteolysis of cyclin E and p27Kip1. Biochem Biophys Res Commun. 2001;282(4):853–60.

Murray AW. Recycling the cell cycle: cyclins revisited. Cell. 2004;116(2):221–34.

Caon I, Bartolini B, Parnigoni A, Caravà E, Moretto P, Viola M, et al. Revisiting the hallmarks of cancer: The role of hyaluronan. In: Seminars in Cancer Biology. Elsevier; 2020. p. 9–19.

Matthews HK, Bertoli C, de Bruin RAM. Cell cycle control in cancer. Nat Rev Mol Cell Biol. 2022;23(1):74–88.

J. Gordon Betts, Kelly A. Young, James A. Wise, Eddie Johnson, Brandon Poe, Dean H. Kruse, Oksana Korol, Jody E. Johnson, Mark Womble PD. Anatomy and Physiology. Houston, Texax: OpenStax; 2013.

Kontomanolis EN, Koutras A, Syllaios A, Schizas D, Mastoraki A, Garmpis N, et al. Role of oncogenes and tumor-suppressor genes in carcinogenesis: A review. Anticancer Res [Internet]. 2020 Nov 1 [cited 2023 Feb 20];40(11):6009–15. Available from: https://ar.iiarjournals.org/content/40/11/6009

Weinberg RA. Oncogenes and Tumor Suppresor Genes. 2020;21(1):1–9. Available from: http://journal.um-surabaya.ac.id/index.php/JKM/article/view/2203

Prior IA, Hood FE, Hartley JL. The frequency of Ras mutations in cancer. Cancer Res. 2020;80(14):2969–74.

Dang C V. MYC on the path to cancer. Cell. 2012;149(1):22–35.

Ren R. Mechanisms of BCR–ABL in the pathogenesis of chronic myelogenous leukaemia. Nat Rev Cancer. 2005;5(3):172–83.

Harari D, Yarden Y. Molecular mechanisms underlying ErbB2/HER2 action in breast cancer. Oncogene. 2000;19(53):6102–14.

Speidel D. The role of DNA damage responses in p53 biology. Arch Toxicol. 2015 Apr;89(4):501–17.

Giacinti C, Giordano A. RB and cell cycle progression. Oncogene [Internet]. 2006 Aug 28 [cited 2023 Feb 20];25(38):5220–7. Available from: https://www.nature.com/articles/1209615

Ye Y-T, Zhong W, Sun P, Wang D, Wang C, Hu L-M, et al. Apoptosis induced by the methanol extract of Salvia miltiorrhiza Bunge in non-small cell lung cancer through PTEN-mediated inhibition of PI3K/Akt pathway. J Ethnopharmacol. 2017;200:107–16.

Yata K, Bleuyard J-Y, Nakato R, Ralf C, Katou Y, Schwab RA, et al. BRCA2 coordinates the activities of cell-cycle kinases to promote genome stability. Cell Rep. 2014;7(5):1547–59.

Waller A, Findeis S, Lee MJ. Familial adenomatous polyposis. J Pediatr Genet. 2016;78–83.

Van Roy F, Berx G. The cell-cell adhesion molecule E-cadherin. Cell Mol life Sci. 2008;65(23):3756–88.

Tsang JYS, Gary MT. Molecular classification of breast cancer. Adv Anat Pathol. 2020;27(1):27–35.

Weigelt B, Horlings HM, Kreike B, Hayes MM, Hauptmann M, Wessels LFA, et al. Refinement of breast cancer classification by molecular characterization of histological special types. J Pathol A J Pathol Soc Gt Britain Irel. 2008;216(2):141–50.

Mármol I, Sánchez-de-Diego C, Pradilla Dieste A, Cerrada E, Rodriguez Yoldi MJ. Colorectal carcinoma: a general overview and future perspectives in colorectal cancer. Int J Mol Sci. 2017;18(1):197.

Burningham Z, Hashibe M, Spector L, Schiffman JD. The epidemiology of sarcoma. Clin Sarcoma Res. 2012;2(1):14.

Davis AS, Viera AJ, Mead MD. Leukemia: an overview for primary care. Am Fam Physician. 2014;89(9):731–8.

Mugnaini EN, Ghosh N. Lymphoma. Prim Care Clin Off Pract. 2016;43(4):661–75.

Hart MN, Earle KM. Primitive neuroectodermal tumors of the brain in children. Cancer. 1973;32(4):890–7.

Wéber A, Morgan E, Vignat J, Laversanne M, Pizzato M, Rumgay H, et al. Lung cancer mortality in the wake of the changing smoking epidemic: a descriptive study of the global burden in 2020 and 2040. BMJ Open. 2023;13(5):e065303.

Kleeff J, Reiser C, Hinz U, Bachmann J, Debus J, Jaeger D, et al. Surgery for recurrent pancreatic ductal adenocarcinoma. Ann Surg. 2007;245(4):566–72.

Liu C-Y, Chen K-F, Chen P-J. Treatment of liver cancer. Cold Spring Harb Perspect Med. 2015;5(9):a021535.